MetaCap

Azora Therapeutics Cash Flow Statement

NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.85-0.02 (-0.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Azora Therapeutics free cash flow

In fiscal 2025, Azora Therapeutics generated -$6.5 million of operating cash flow. That left free cash flow of -$6.5 million.

Summary generated from market data by MetaCap's automated system. Methodology

Azora Therapeutics cash flow statement (annual)

Azora Therapeutics annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31
Net Income-7.98M-13.20M-5.12M-12.73M-19.42M-10.89M-8.59M-11.63M-1.14M
Net Income growth (YoY)—————————
Stock-Based Compensation676.20K796.83K1.75M3.37M4.24M2.01M1.60M5.37M205.40K
Change in Working Capital108.87K263.07K-691.21K-1.36M-278.92K941.14K239.13K-343.36K327.07K
Operating Cash Flow-6.49M-6.92M-6.81M-11.19M-11.95M-7.63M-6.34M-2.50M-494.86K
Capital Expenditures————-64.61K————
Investing Cash Flow150.00K—1.50M—-34.02K-350.00K——35.12K
Share Repurchases——-1.66K——————
Debt Issued——9.12M————275.00K—
Debt Repaid———————-150.00K—
Financing Cash Flow8.47M7.85M4.13M9.13M13.64M5.61M9.25M6.35M390.00K
Net Change in Cash2.13M923.44K-1.17M-2.06M1.66M-2.38M2.91M3.85M-69.75K
Free Cash Flow-6.49M-6.92M-6.81M-11.19M-12.01M-7.63M-6.34M-2.50M-494.86K

This table shows 9 annual periods of Azora Therapeutics's cash flow statement, from FY 2025 back to FY 2017, across 12 line items including net income, stock-based compensation, change in working capital. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a cash flow statement?

More financial data